FDA And White House Fast-Track Drug Approvals And Innovate On Prices

In a sweeping set of policy announcements that combine speed with cost control, the U.S. Food and Drug Administration (FDA) and the White House unveiled a new package of measures designed to accelerate access to high-priority medicines and lower…

Continue Reading